Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in VRCA — Verrica Pharmaceuticals Inc.

CIK 19617 NEW YORK, NY
Back to VRCA Full portfolio

Position in VRCA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$287
+$39 QoQ
Shares Held
47
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 43 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRCA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. VRCA ranks #380 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in VRCA

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $287 47
2026-03-31 $248 47
2025-12-31 $390 47
2025-03-31 $8,975 20,309
2024-12-31 $6,662 9,518
2024-09-30 $12,865 8,873
2024-06-30 $63,086 8,654
2024-03-31 $51,793 8,749
2023-12-31 $99,507 13,594
2023-09-30 $52,811 13,594
2023-06-30 $103,114 17,871
2023-03-31 $8,027 1,235
2022-12-31 $3 1,235
2022-09-30 $7,886 2,701
2022-06-30 $2,067 1,077
2022-03-31 $75,965 9,367
2021-12-31 $225,197 24,585
2021-09-30 $381,400 30,512
2021-06-30 $489,775 43,343
2021-03-31 $420,275 27,741
2020-12-31 $63,397 5,508
2020-09-30 $35,890 4,637
2020-06-30 $60,796 5,522
2020-03-31 $45,391 4,153